This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Western European Endoscopic Devices Market To Benefit From Increase In Minimally Invasive Surgeries, Says Frost & Sullivan

LONDON, April 10, 2013 /PRNewswire/ -- The rise in the number of minimally invasive surgeries (MIS) is promoting the use of endoscopy devices. These devices provide the necessary visualisation during MIS procedures.

New analysis from Frost & Sullivan ( http://www.medtech.frost.com), Western European Endoscopy Devices Market, finds that the market earned revenues of $2.96 billion in 2012 and estimates this to reach $4.44 billion in 2019. The research covers the potential for rigid and flexible endoscopes and endoscopy equipment and accessories across applications in arthroscopy, ENT, gastrointestinal, gynaecology, laparoscopy, neurology, pulmonary and urology.

"In the existing managed care environment, MIS procedures – which offer both clinical and cost benefits – are increasing at a faster pace than conventional surgical procedures," notes Frost & Sullivan Healthcare Research Analyst Brahadeesh Chandrasekaran. "This is expected to be a key driving factor for endoscopy devices."

Endoscopy's advantage over traditional surgery is attributed to its ability to provide a visual, while being minimally invasive. This is motivating the use of these devices in various surgical techniques. For instance, endoscopy techniques such as arthroscopy, a major surgical endoscopic technique that focused primarily on the knee, is now expanding to other areas such as the shoulder, the wrist and small peripheral joints.

Endoscopy has become a common procedure in various fields such as urology, gynaecology and gastroenterology. In the future, endoscopy may be the standard procedure for the diagnosis and treatment of most internal organ disorders, as well as for the treatment of liver, colorectal and other types of cancer.

"The sale of technologically advanced products, such as video-endoscopes and capsule endoscopes, indicate that there is a huge demand for advanced, innovative products," adds Chandrasekaran. "Although these devices are initially challenged by the lack of reimbursement, penetration levels are set to rise subsequent to strong clinical evidence being provided."

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs